News Daily News Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk Caitlin E. Cox February 13, 2026
News Daily News Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION Todd Neale December 16, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Daily News Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations L.A. McKeown January 31, 2025
News Conference News AHA 2023 ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients Todd Neale November 13, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Daily News Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows L.A. McKeown April 12, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk Michael O'Riordan March 23, 2021
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Industry News Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease May 08, 2018
News Conference News EAS 2018 Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention Yael L. Maxwell May 07, 2018